Shows / Squawk Pod

Squawk Pod
Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box”, anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer.
Episodes
Squawk PodBiden’s First Moves; New Hampshire’s Governor; A Dark Anniversary
Just over 24 hours in office, President Biden has signed a series of executive actions on the pandemic, immigration, and climate change. CNBC’s Eamon Javers…
Squawk PodLeon Cooperman on Inauguration Day
Billionaire investor and philanthropist Leon Cooperman, Chairman and CEO of Omega Family Office, discusses his vote for President Joseph R. Biden, Jr…
Squawk PodThe “Art” of Healing with Arthur Brooks; Vaccine Supply with Dr. Scott Gottlieb
Dr. Scott Gottlieb discusses coronavirus vaccine supply, likelihood of bottlenecks, and threats to equitable distribution. Harvard Professor, AEI President…
Squawk PodBiden’s $1.9T Plan; Big Tech’s Next Steps; IPO Fever
President-Elect Joe Biden has unveiled his $1.9T Covid relief package, and his newly appointed Council of Economic Advisers Member Jared Bernstein makes the…
Squawk PodKen Langone: I feel betrayed
In an extended interview, billionaire Republican, Invemed Chairman, and Home Depot co-founder Ken Langone speaks out against reluctance to accept…
Squawk PodCorporate Money Talks…& Walks
Corporate executives across the country are reassessing their political donations in the wake of last week’s violence in the Capitol. Former EY Global Chairman…
Squawk PodVaccine Bottlenecks with Pfizer CEO; Big Tech’s Path Forward with Cambridge Analytica Whistleblower
Leaders in Washington and on Wall Street are grappling with conservative allegiances as lawmakers approach a vote on impeachment and corporate America cuts off…
Squawk PodThe Platform Power Debate: Publishers, Parler, & The President
Parler, the social app favored by conservative Americans, found itself on the wrong side of Apple, Amazon, and Google in the wake of last week’s riots in the…
Squawk PodLeadership Amid Chaos: Carlyle’s David Rubenstein & Ariel’s Mellody Hobson
In the wake of the riots at the Capitol, America’s C-suites are speaking out, some calling for President Trump’s removal from office, others urging a…
Squawk PodDemocracy, the Day After
Hours after a mob of pro-Trump rioters breached the United States Capitol and disrupted the Presidential certification process, Congress certified…
Squawk PodChina’s Plans, Georgia’s Polls, Palantir’s Co-Founder, & Sowing Oatly: Planning a Debut
As Georgia’s final runoff votes are counted, Joe Lonsdale, Palantir co-founder and 8VC founding partner, considers how the state’s races are impacting market…
Squawk Pod2021 Surprises; Jack Ma’s Mystery; An Exchange’s About Face; Haven’s End
Jack Ma, co-founder of Alibaba, Chinese tech celebrity, and outspoken innovator in China, has not been seen in public for two months. China Beige Book…
Squawk PodGeorgia’s Votes in Focus; WW’s New Year Resolutions
As the final count in Georgia’s runoff elections draws nearer, Axios co-founder Jim Vandehei breaks down what’s at stake on both sides of the aisle. CNBC’s…
Squawk PodFarewell, 2020: Market Wrap, China’s Progress, & Next Year’s Georgia
In the final episode of the year, CNBC Beijing Bureau Chief Eunice Yoon shares life in China, a year after the world’s first case of Covid-19 within its…
Squawk PodThe $2000 Check Debate with Senator Toomey & The $1B+ Club: Unqork
Senator Pat Toomey (R-PA) shares why he remains against upping the American stimulus checks from $600 to $2000 amid the pandemic. CNBC’s Senior Economics…
Squawk PodBoeing 737 Max Return, & The $1B+ Club: MessageBird
American Airlines is operating the first U.S. flight of the Boeing 737 Max since the craft was grounded in March or 2019. CNBC’s Auto and Airline Industry…
Squawk PodAnt Group, Intimates, & The $1B+ Club: Klaviyo
This year has been painful for many businesses, but some tech-focused startups have managed to thrive amid the pandemic. In the $1B+ Club series debut, founder…
Squawk Pod2020: The Year That Was
In an original conversation exclusive to Squawk Pod, anchors Joe Kernen and Becky Quick reflect on the roller coaster year of the pandemic--market turns, tech…
Squawk PodDeal or No Deal with NYT’s Tom Friedman; Vaccines, Strains, & Safety with Dr. Atul Gawande
After last minute input from President Trump, the $900B relief bill passed by Congress may be back to the negotiating table. The New York Times Columnist Tom…
Squawk PodThe Self-Driving Apple of Tim Cook’s Eye, & Relief, “A Christmas Miracle”
Apple’s efforts to get its own electric passenger vehicle on the road might finally be picking up speed. The Sunday Times West Coast Correspondent Danny…
Squawk PodCovid’s New Strain; University Tuitions Freezing Over; Tracking Wealth Threats
New strains of the Covid-19 virus have been found in Britain and South Africa and doctors are warning it could be even more contagious than the original…
Squawk Pod(Vaccine) Jabs at the White House
Vice President Mike Pence received the Pfizer-BioNTech Covid-19 vaccine in a televised appearance today in an effort to boost public confidence in its…
Squawk PodHHS Secretary Alex Azar; Media Deal Mogul Aryeh Bourkoff
As the U.S. works to ensure efficient and effective vaccine distribution, Health and Human Services Secretary Alex Azar urges Americans to remain cautious…
Squawk PodVaccine Rollout; Russian Hack; Who are you Calling Overweight?
Only 5% to 20% of the coronavirus antibody drugs that have been shipped across the U.S. are being used to treat people who are infected according to CNBC’s…
Squawk PodBuffett on Small Business: ‘It’s an economic war’
Berkshire Hathaway Chairman Warren Buffett and Goldman Sachs CEO David Solomon address the biggest challenges facing the backbone of the American economy: the…
Squawk PodD-Day; Pfizer CEO on Vaccine Roll-out: ‘Trust science’
An historic day after months of research and clinical trials, the Pfizer-BioNTech Covid vaccine delivery is underway, with millions of doses being distributed…
Squawk PodI-P-Whoa! Airbnb Takes Off
Airbnb co-founder and CEO Brian Chesky sat down with Andrew Ross Sorkin ahead of the company’s landmark IPO. Public listings have been on a tear this year in…
Squawk PodCVS Health CEO; “10,000 staffers are ready to vaccinate” & Starbucks’ 2021 Rebound
The Food and Drug Administration votes today on whether to recommend the approval of Pfizer and BioNTech’s coronavirus vaccine for emergency use. CVS Health…
Squawk PodStimulus (Again), SALT-y Debates & Covid Brain Fog
Senate Majority Leader Mitch McConnell says he wants Congress to pass a coronavirus relief bill with neither legal immunity for businesses nor state and local…
Squawk PodUber CEO & a Self-Driving Deal; Shopify President & the 2021 Consumer; The UK & its V-Day
The United Kingdom has administered the coronavirus vaccine to its first recipient just 10 months after Covid-19 took hold around the globe. Shopify is making…
Squawk PodThe IPO Parade; Dr. Scott Gottlieb & Indoor Dining; Axios’s Mike Allen
Axios co-founder Mike Allen reveals what he’s watching as we approach the Presidential inauguration on January 20th. Former FDA Commissioner Dr. Scott Gottlieb…
Squawk PodHollywood’s Watershed Moment; DocuSign’s Strong Quarter; NYT’s Call with President-Elect Biden
Tom Friedman, New York Times foreign affairs columnist, shares takeaways from his conversation with President-Elect Joe Biden as negotiations for stimulus wear…
Squawk PodThe IRS is Eyeing Crypto; Discovery is Entering the Streaming Wars
Discovery is the latest media company to jump into the streaming wars with Discovery+. Discovery CEO David Zaslav and Verizon Consumer Group CEO Ronan Dunne…
Squawk PodRenting the Pandemic Runway & Diversify, or Delist: the Nasdaq’s New Rule with Ursula Burns & Darren Walker
The Nasdaq has proposed a new rule to require its 3,000+ listed companies to disclose Board of Directors demographics. Ursula Burns, former Xerox CEO and board…
Squawk PodZoom, Run, Negotiate, Repeat
In the new normal of distanced, remote activities, video conferencing services like Zoom and gym-free fitness companies like Brooks Running have become staples…
Squawk PodThe Power of Pandemic Rhetoric; The Winklevoss Bitcoin Bulls
In the wake of the Thanksgiving holiday, former FDA Commissioner Dr. Scott Gottlieb discusses the rise in coronavirus cases and the troublesome trend that’s…
Squawk PodBlack Friday, Bonuses, & Bitcoin
On a Black Friday unlike any other, CNBC’s Bertha Coombs reports on the scene outside a New Jersey mall. Former Saks CEO Steve Sadove and former Walmart U.S…
Squawk Pod“Grateful” with Singer-Songwriter Jewel
In a special pandemic holiday episode, singer-songwriter Jewel opens up about her history with mental health, overcoming trauma, and practicing gratitude. As…
Squawk PodFirst Timer Turkey Cooking Tips; MTA’s $12B Pitch; Dow’s 30K Milestone
The Dow Jones Industrial Average closed above 30,000 for the first time ever, putting the index up 62% from its pandemic lows in March. The MTA, the biggest…
Squawk PodCrypto Bets with PayPal CEO; A U.S. Treasury with Janet Yellen; QR Codes & Snow Sports
PayPal customers will soon be able to buy, hold, and sell cryptocurrencies on the platform, and starting in 2021, customers will be able use crypto to pay…
Squawk PodAstraZeneca in the Vaccine Race; Ballots in Georgia
AstraZeneca’s Covid vaccine is the third one to prove highly effective in late-stage trials. AstraZeneca Executive Vice President Ruud Dobber explains…
Squawk PodCovid Milestones: Eli Lilly CEO on Antiviral Approval, Pfizer’s FDA Application, & Getting Back to the Movies
Pfizer is submitting its application to the FDA for emergency use of its Covid-19 vaccine. If approved, administration of the vaccine could begin before the…
Squawk PodSEC Chairman Exit Interview; Vaccine Supply & Distribution; David Boies & an Uncontestable Election
David Boies, the lawyer who counseled former Vice President Al Gore in the 2000 election Florida recount, says President Trump will be unable to overturn the…
Squawk PodBoeing’s 737 Max Returns; Pfizer’s Covid Vaccine Proves 95% Effective
As Covid cases rise and states impose new curfews to stem the spread, Pfizer & BioNtech have unveiled their coronavirus vaccine’s final data analysis. Their…
Squawk PodBuffett’s Quarterly Bets; Tesla’s Index Inclusion; Amazon’s Drug Biz; Newsmax’s Editorial Appeal
The S&P 500 will finally add Tesla to its index in mid-December. Elon Musk’s electric vehicle company now tops $400B in market cap. Warren Buffett’s Berkshire…
Squawk PodThe 94.5%: Moderna’s Covid Vaccine with CEO Stephane Bancel
In Moderna’s ongoing clinical trial, the drugmaker’s Covid vaccine proved 94.5% effective in preventing the coronavirus. In an exclusive interview, CEO…
Squawk PodReddit Co-Founder Alexis Ohanian; A Pitch for Restaurant Rescue
Social media entrepreneur and venture capitalist Alexis Ohanian urges Americans to consider the role social platforms should play in society. He examines where…
Squawk PodThe Parley on Parler; The Bull Market with Morgan Stanley’s Mike Wilson
Parler, a new social media platform that touts itself as a less censored alternative to Facebook and Twitter, is rising in popularity, particularly among…
Squawk PodVeterans Day with General David Petraeus; Lyft President John Zimmer
In a rare interview, Lyft co-founder and President John Zimmer discusses the ridesharing app’s path to profitability, plans for food delivery (or not), and a…
Squawk PodBET’s Bob Johnson; Tesla’s Refunds; Target’s Makeup Counters
In the wake of Pfizer’s positive vaccine news, markets are rallying on hopes of a light at the end of the pandemic tunnel. BET and RLJ Companies founder Bob…
Squawk PodLessons from Election Market History; “The Black Swan” Author Nassim Taleb
Ed Clissold, market strategist for Ned Davis Research Group, puts this week’s election in perspective with market and election data going back to 1900…
Squawk PodBreakthrough: Pfizer's Vaccine & “A Great Day for Humanity” with CEO Albert Bourla
In what Pfizer CEO Albert Bourla calls “likely the most significant medical advancement in the last 100 years,” BioNtech and Pfizer’s Covid-19 vaccine may…
Squawk PodElection Day, Continued: Leon Cooperman, Uber CEO, & Arthur Brooks
Legendary investor Leon Cooperman explains his approach to markets amid the ongoing Presidential vote and the Federal Reserve’s approach to stabilizing the…
Squawk Pod“It’s Got to End at Some Point, for the Good of the Country”
As 2020 election results trickle in, Al Gore’s running mate former Senator Joe Lieberman reflects on the 34 controversial days between Election Day in 2000 and…
Squawk PodHe’s a Political Force: Barry Diller & David Rubenstein, the Morning After
As votes are counted across the country, David Rubenstein, co-founder and co-executive chairman of The Carlyle Group, expects market jitters to continue until…
Squawk PodElection Day 2020: The United States of Anxiety
Election Day 2020 is finally here. At this culmination of America’s anxieties, former Facebook Chief Security Officer Alex Stamos discusses social media’s…
Squawk PodCounting on Confidence: Vaccines with Dr. Atul Gawande & Investor Sentiment Beyond Election Day
Dr. Atul Gawande, Chairman of Haven, surgeon, and staff writer for The New Yorker, shares his expectations for coronavirus vaccine supply and American…
Squawk PodVaccines & Voting with Merck CEO; Tech & Politics on the Hill
Ken Frazier, CEO of drug maker Merck, maps out his timeline for a coronavirus vaccine as cases continue to rise around the world. In a conversation with Yale…
Squawk PodRobinhood CEO Vlad Tenev: The Rise of the Retail Investor
Robinhood, the trading app that took young people and financiers by storm, now boasts 13 million user accounts. Its zero-commission trading model prompted an…
Squawk PodEli Lilly CEO on Antibody Trial’s Finish; CEOs Get Out the Vote
The National Institutes of Health has halted one of Eli Lilly’s coronavirus antibody trials, having found that the combination of Lilly’s antibody drug and…